Free Trial

Patterson Companies (PDCO) Competitors

Patterson Companies logo
$31.07 +0.01 (+0.03%)
Closing price 02/21/2025 04:00 PM Eastern
Extended Trading
$31.07 0.00 (0.00%)
As of 02/21/2025 04:05 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

PDCO vs. HSIC, OMI, MCK, COR, CAH, MEDP, TECH, PCVX, SRPT, and PEN

Should you be buying Patterson Companies stock or one of its competitors? The main competitors of Patterson Companies include Henry Schein (HSIC), Owens & Minor (OMI), McKesson (MCK), Cencora (COR), Cardinal Health (CAH), Medpace (MEDP), Bio-Techne (TECH), Vaxcyte (PCVX), Sarepta Therapeutics (SRPT), and Penumbra (PEN). These companies are all part of the "medical" sector.

Patterson Companies vs.

Patterson Companies (NASDAQ:PDCO) and Henry Schein (NASDAQ:HSIC) are both mid-cap medical companies, but which is the superior investment? We will compare the two companies based on the strength of their community ranking, dividends, analyst recommendations, risk, earnings, profitability, institutional ownership, media sentiment and valuation.

Henry Schein received 16 more outperform votes than Patterson Companies when rated by MarketBeat users. Likewise, 51.64% of users gave Henry Schein an outperform vote while only 50.63% of users gave Patterson Companies an outperform vote.

CompanyUnderperformOutperform
Patterson CompaniesOutperform Votes
362
50.63%
Underperform Votes
353
49.37%
Henry ScheinOutperform Votes
378
51.64%
Underperform Votes
354
48.36%

Henry Schein has higher revenue and earnings than Patterson Companies. Patterson Companies is trading at a lower price-to-earnings ratio than Henry Schein, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Patterson Companies$6.55B0.42$185.93M$1.7118.17
Henry Schein$12.34B0.78$416M$2.4331.79

85.4% of Patterson Companies shares are held by institutional investors. Comparatively, 96.6% of Henry Schein shares are held by institutional investors. 1.9% of Patterson Companies shares are held by insiders. Comparatively, 1.1% of Henry Schein shares are held by insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a company is poised for long-term growth.

Patterson Companies has a beta of 0.9, indicating that its share price is 10% less volatile than the S&P 500. Comparatively, Henry Schein has a beta of 0.91, indicating that its share price is 9% less volatile than the S&P 500.

Patterson Companies currently has a consensus price target of $26.57, indicating a potential downside of 14.48%. Henry Schein has a consensus price target of $80.09, indicating a potential upside of 3.69%. Given Henry Schein's stronger consensus rating and higher probable upside, analysts clearly believe Henry Schein is more favorable than Patterson Companies.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Patterson Companies
0 Sell rating(s)
10 Hold rating(s)
1 Buy rating(s)
0 Strong Buy rating(s)
2.09
Henry Schein
0 Sell rating(s)
7 Hold rating(s)
5 Buy rating(s)
1 Strong Buy rating(s)
2.54

Henry Schein has a net margin of 2.51% compared to Patterson Companies' net margin of 2.37%. Patterson Companies' return on equity of 19.77% beat Henry Schein's return on equity.

Company Net Margins Return on Equity Return on Assets
Patterson Companies2.37% 19.77% 6.66%
Henry Schein 2.51%12.90%5.21%

In the previous week, Henry Schein had 5 more articles in the media than Patterson Companies. MarketBeat recorded 10 mentions for Henry Schein and 5 mentions for Patterson Companies. Henry Schein's average media sentiment score of 0.88 beat Patterson Companies' score of 0.84 indicating that Henry Schein is being referred to more favorably in the news media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Patterson Companies
3 Very Positive mention(s)
1 Positive mention(s)
1 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive
Henry Schein
7 Very Positive mention(s)
2 Positive mention(s)
1 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive

Summary

Henry Schein beats Patterson Companies on 16 of the 19 factors compared between the two stocks.

Get Patterson Companies News Delivered to You Automatically

Sign up to receive the latest news and ratings for PDCO and its competitors with MarketBeat's FREE daily newsletter.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

PDCO vs. The Competition

MetricPatterson CompaniesMedical & hospital equipment IndustryMedical SectorNASDAQ Exchange
Market Cap$2.74B$7.80B$5.77B$8.99B
Dividend Yield3.35%2.01%4.78%3.85%
P/E Ratio18.1721.9426.4618.82
Price / Sales0.421.12453.6978.73
Price / Cash9.1710.8244.0437.47
Price / Book2.782.137.634.64
Net Income$185.93M$259.21M$3.18B$245.69M
7 Day Performance0.13%-4.43%-1.91%-2.66%
1 Month Performance0.49%-15.76%-0.19%-2.15%
1 Year Performance9.71%-17.73%16.70%12.90%

Patterson Companies Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
PDCO
Patterson Companies
4.2925 of 5 stars
$31.07
+0.0%
$26.57
-14.5%
+11.6%$2.74B$6.55B18.177,600Upcoming Earnings
HSIC
Henry Schein
3.8649 of 5 stars
$76.00
-2.1%
$80.09
+5.4%
+2.9%$9.48B$12.34B31.2825,000Upcoming Earnings
OMI
Owens & Minor
4.5972 of 5 stars
$7.45
-3.8%
$16.79
+125.5%
-71.4%$574.08M$10.33B-11.4513,700Upcoming Earnings
Analyst Revision
MCK
McKesson
4.7137 of 5 stars
$593.82
-1.4%
$645.79
+8.8%
+17.8%$75.38B$308.95B27.1951,000Insider Trade
Positive News
COR
Cencora
4.4245 of 5 stars
$243.03
-0.6%
$277.90
+14.3%
+3.4%$46.97B$638.56M34.5746,000Positive News
CAH
Cardinal Health
4.7876 of 5 stars
$126.35
-0.3%
$136.87
+8.3%
+20.2%$30.52B$226.83B23.5748,900Positive News
MEDP
Medpace
4.1756 of 5 stars
$340.17
-0.7%
$381.44
+12.1%
-11.8%$10.57B$1.89B29.795,900
TECH
Bio-Techne
4.9282 of 5 stars
$65.94
-1.2%
$86.57
+31.3%
-9.5%$10.48B$1.16B66.613,100Analyst Downgrade
Insider Trade
PCVX
Vaxcyte
2.5871 of 5 stars
$84.00
+0.2%
$127.71
+52.0%
+10.4%$10.47BN/A-18.26160Insider Trade
Positive News
SRPT
Sarepta Therapeutics
4.4948 of 5 stars
$107.95
-1.4%
$176.77
+63.8%
-19.7%$10.31B$1.24B86.361,314Upcoming Earnings
PEN
Penumbra
4.4614 of 5 stars
$267.83
-1.9%
$261.36
-2.4%
+13.4%$10.28B$1.06B311.434,200Earnings Report
Analyst Forecast
Analyst Revision
News Coverage

Related Companies and Tools


This page (NASDAQ:PDCO) was last updated on 2/22/2025 by MarketBeat.com Staff
From Our Partners